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Introduction
Cultured yogurts and probiotics are a 
$28 billion worldwide industry1 and are 
relatively cheap and readily available to 
consumers in supermarkets, pharmacies, and 
hospitals. They come in a variety of 
different forms, including commercial 
yogurts and capsules, and are well known in 
the baking and brewing industries. Many 
health care providers recommend cultured 
yogurts/probiotics for patients with altered 
bowel flora to restore the functional integrity 
of the bowel. There have been multiple adult 
randomized controlled trials2-7 of marginal 
quality that have shown the ability of these 
agents to prevent diarrhea associated with 
antibiotic usage and have been proposed to 
be used in conditions such as Crohn’s 
disease and other inflammatory bowel 
conditions.8 
Despite harboring live bacteria and/or 
fungi, cultured yogurts and probiotics are an 
uncommon cause of infection in humans9 
and generally have been deemed effective 
and safe.2 They are considered the “good 
bacteria” by many and, by definition, should 
be beneficial to the ingesting host. However, 
with an increase in the population at risk for 
chronic and debilitating diseases with 
exposure to significant risk factors, such as 
the use of immunosuppressive drugs and 
broad spectrum antibiotics, parenteral 
nutrition, and use of central venous 
catheters, the number of reported cases of 
infections due to these agents over the last 
century is clearly on the rise.10 
 
Case Report 
A 61-year-old male with a history of 
testicular germ cell cancer status post 
allogenic stem cell transplant and 
neutropenic from immunosuppressive 
therapy presented with abdominal pain and 
fever. Temperature was 100.1oF, blood 
pressure 128/68 mm Hg, pulse rate 85 beats 
per minute, and respiratory rate 18 times per 
minute. Initial blood count revealed a white 
blood cell count of 1.3 K/uL, platelet count 
of 20 K/uL, and an absolute neutrophil count 
of 0. A comprehensive metabolic panel 
(CMP) showed glucose of 110 mg/dL, 
creatinine of 1.58 mg/dL, sodium of 129 
mEq/L, and albumin of 2.9 g/dL. Alpha fetal 
protein was 771 IU/mL. Urine culture 
showed no growth and Clostridium difficile 
toxin B by polymerase chain reaction was 
positive. Chest x-ray showed developing 
infiltrate and pulmonary edema (Figure 1). 
The patient was started on metronidazole 
and improved over the course of the next 
few days, then suddenly deteriorated and 
was transferred to the medical intensive care 
unit with  septic shock and respiratory 
failure requiring mechanical ventilation. 
Blood and sputum cultures showed S. 
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cerevisiae. Subsequently, the patient’s wife 
reported that she had been encouraged by 
the nursing staff and dietitians to feed her 
husband cultured yogurt sprinkled with 
probiotic powder to restore bowel flora. 
Aspiration (due to altered mental status), 
gastrointestinal tract translocation (due to 
altered mucosal integrity from clostridium 
difficile-associated diarrhea), and severe 
immunocompromised state (from chemo-
therapy) likely contributed to his 
deterioration. He recovered with 
voriconazole therapy which was based on 
sensitivities.  
 
 
Figure 1. Chest x-ray showed developing 
infiltrate and pulmonary edema. 
 
Further review of records revealed 
another case of invasive S. cerevisiae 
infection in the same hospital that occurred 
within months of the above case. The patient 
was a liver transplant recipient who had 
previous abdominal surgery and also 
presented with abdominal pain and severe 
sepsis. Initial temperature was 98.5oF, blood 
pressure 83/54 mm Hg, pulse rate 110 beats 
per minute, and respiratory rate 17 times per 
minute. Initial laboratory revealed a white 
blood count of 28.8 K/uL and a platelet 
count of 592 K/uL. A CMP showed glucose 
of 117 mg/dL, creatinine of 0.7 mg/dL, 
sodium of 135 mEq/L, and potassium of 4 
mEq/L. Computed topography (CT) of the 
abdomen and pelvis showed 23 mm x 38 
mm and 45 mm x 51 mm walled off areas 
suspicious for abscesses (Figures 2 and 3). 
CT-guided drainage and culture of the 
abscesses revealed S. cerevisiae.  
This patient also was encouraged by the 
nurses and dietitians to eat cultured yogurt 
with probiotics to restore bowel flora. She 
was on an immunosuppressive transplant 
regimen and had previous bowel surgeries 
that likely contributed to the organism 
translocating through the gastrointestinal 
mucosa and contributed to abscess 
formation. This patient also improved with 
antifungal therapy. 
 
 
Figure 2. Walled-off abscess located near 
the right rectum. 
 
 
Figure 3. Large abscess in the left pelvis 
filled with contrast. 
 
Discussion 
Few cases of complications from S. 
cerevisiae have been reported. The number 
of documented infections from the ingestion 
of cultured yogurts and probiotics is in-
creasing and considered an emerging type of 
infectious disease.9 Since the mid-1900s, 
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roughly 60-100 cases of S. cerevisiae 
fungemia from cultured yogurts/probiotics 
have been identified.9,11,12 Data released in 
the near future undoubtedly will show a 
higher number of cases of S. cerevisiae 
fungemia.  
Probiotic-related fungemia may be 
asymptomatic or severe with unexplained 
fever, fungemia, endocarditis, pneumonia, 
liver abscess, peritonitis, and septic shock.13  
Although the vast majority of reported cases 
occur in patients who are critically ill with 
significant comorbidities, S. cerevisiae 
should be considered a potentially 
dangerous micro-organism as there are cases 
causing fungemia in immunocompetent 
patients as well.9 Also, patients may not 
report they are ingesting cultured yogurt and 
probiotics as historically they have been 
viewed as benign, health promoting agents 
with no side effects. Patients should be 
asked about probiotic and cultured yogurt 
use when gathering historical data. 
Enteral translocation of ingested micro-
organisms (as in the cases described above) 
is a potential portal of entry into the 
bloodstream.10 Approximately two-thirds of 
patients with S. cerevisiae fungemia had 
previous digestive tract disease.12 Scant 
data, however, specifically document intra-
abdominal abscess caused by S. cerevisiae, 
which makes the second case above unique.  
According to the Infectious Disease 
Society of America (IDSA),13 routine 
administration of available probiotics is not 
recommended to prevent primary C. difficile 
infection as there are limited data to support 
this approach and there is a potential risk of 
bloodstream infection. There is a potential 
benefit of using probiotics containing S. 
cerevisiae (subtype boulardi) with oral 
vancomycin to reduce the recurrence of C. 
difficile, however, the IDSA discourages 
routine usage of probiotics in critically ill 
patients and warns of potential fungemia if 
used in immunocompromised patients. 
Other national/international medical 
authorities (e.g., United Kingdom Health 
Protection Agency, American College of 
Physicians, World Gastroenterology 
Organization) have no definitive statements 
with regards to the overall safety of 
probiotic usage with antibiotic-associated 
diarrhea and C. diff-associated diarrhea.2  
 
Conclusion 
There is marginal randomized data on 
the effectiveness of probiotics to prevent 
antibiotic-associated and C. difficile-
associated diarrhea. The recent increase in 
incidence and severity of disease caused by 
hypervirulent strains of C. difficile has 
prompted some clinicians to increase their 
use of probiotics as drugs in combination 
with standard antimicrobial drug therapy. 
However, many organizations, such as the 
IDSA, do not recommend the routine usage 
of probiotics due to potential complications.  
Clinicians should be aware that probiotic 
dietary supplements are not required by the 
US Food and Drug Administration to 
undergo rigorous premarketing evaluations 
for efficacy or safety.13 Furthermore, there 
have been multiple reports about 
complications such as fungemia from these 
agents. Saccharomyces cerevisiae should be 
considered as an emerging cause of 
nosocomially acquired yeast infection and 
the risks and benefits of probiotics should be 
carefully assessed, particularly in immuno-
suppressed or critically ill patients.9 
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